Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease
Methods are provided for treating chronic obstructive pulmonary diseases such as emphysema using compounds that activate the signaling pathways of hepatocyte growth factor.
1. A method for treating a chronic obstructive pulmonary disease comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising a carrier and a compound selected from among
2. The method of claim 1 wherein the chronic obstructive pulmonary disease is emphysema.
3. The method of claim 1 wherein the chronic obstructive pulmonary disease is secondary to tobacco abuse or smoking.
4. A method for treating a chronic obstructive pulmonary disease comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising a carrier and a compound selected from among
5. The method of claim 4 wherein the chronic obstructive pulmonary disease is emphysema.
6. The method of claim 4 wherein the chronic obstructive pulmonary disease is secondary to tobacco abuse or smoking.
7. A method for treating a chronic obstructive pulmonary disease comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising a carrier and a compound selected from among
8. The method of claim 7 wherein the chronic obstructive pulmonary disease is emphysema.
9. The method of claim 7 wherein the chronic obstructive pulmonary disease is secondary to tobacco abuse or smoking.
10. A method for treating a chronic obstructive pulmonary disease comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition comprising a carrier and a compound selected from among
11. The method of claim 10 wherein the chronic obstructive pulmonary disease is emphysema.
12. The method of claim 10 wherein the chronic obstructive pulmonary disease is secondary to tobacco abuse or smoking.